克鲁佩尔之类因子4,瘤微环境中细胞交叉通话的枢纽门
Min Tang1, Binle Tian1, Jingyi Zhou1
1Department of Medical Oncology, Cancer Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Cancer medicine
|January 14, 2026
概括
克鲁佩尔样因子4 (KLF4) 在癌症中具有双重作用,作为瘤抑制剂或瘤基因. 它在瘤微环境 (TME) 中的复杂功能为向癌症治疗提供了潜在的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 克鲁佩尔样因子4 (KLF4) 是一种转录因子,在癌症中具有上下文依赖的作用.
- KLF4可以作为瘤抑制剂或瘤基因起作用.
- 它在瘤微环境 (TME) 中的复杂作用对癌症进展至关重要.
研究的目的:
- 综合审查KLF4在TME中的多方面的作用.
- 评估KLF4作为瘤学中的潜在治疗点.
- 了解KLF4在TME中的细胞交叉声调的编排.
主要方法:
- 综合文献综述. 这是一个全面的文献综述.
- 分析KLF4表达模式和调节机制.
- 调查KLF4在各种TME组件 (癌细胞,免疫细胞,纤维细胞等) 的功能. ) 的情况.
主要成果:
- KLF4表现出相反的作用:胃癌,肺癌和胰腺癌中的瘤抑制剂;乳腺癌,结肠直肠癌和前列腺癌中的瘤基因.
- KLF4调节巨细胞极化,T细胞耗尽,NK细胞活动,以及骨髓系衍生抑制细胞的招募.
- KLF4影响与癌症相关的纤维细胞激活和细胞外矩阵重塑,其表达由miRNAs,lncRNAs和表观遗传学调节.
结论:
- KLF4作为TME内部细胞间通信的中央调节器.
- 了解KLF4的特定环境功能是开发精密瘤治疗的关键.
- 新兴的KLF4向剂在临床前和早期临床环境中表现有前途.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K


